Development of a Structural Model Explaining Medication Compliance of Persons with Schizophrenia.
10.3349/ymj.2005.46.3.331
- Author:
Mi A SEO
1
;
Sung Kil MIN
Author Information
1. Department of Social Welfare, Seoul Cyber University, Seoul, Korea. sma5014@iscu.ac.kr
- Publication Type:Original Article
- Keywords:
Medication compliance;
schizophrenia
- MeSH:
Adult;
Antipsychotic Agents/*administration & dosage;
Female;
Humans;
Male;
*Models, Psychological;
Patient Compliance/*psychology;
Schizophrenia/*drug therapy;
Self Administration/*psychology;
Social Support
- From:Yonsei Medical Journal
2005;46(3):331-340
- CountryRepublic of Korea
- Language:English
-
Abstract:
The purpose of this study was to develop and test a structural model explaining medication compliance of schizophrenia. From a review of the literature, a hypothetical model was developed based on the conceptual framework of the Health Belief Model with medication knowledge, symptom severity and social support as the exogenous variables, and perceived benefits, perceived barriers, substance use and medication compliance as the endogenous variables. Data was collected at various mental health facilities, including psychiatric outpatient clinics of general hospitals and community mental health centers, between March and May, 2001. A structured questionnaire was used by one- on- one interviews to collect data on 208 schizophrenic patients. Well established measurement instruments, with confirmed reliability, were used to assess each method variable. As a result of covariance structural analysis, the hypothetical model was found not to fit the empirical data well, so a parsimonious model was adopted after modifying the model. The final model was able to explain the 33% medication compliance. Medication knowledge, social support and perceived benefits had significant effects on medication compliance. The findings of this study address the importance of medication education and social support to promote medication compliance. It is also suggested that various education programs and support groups are needed to enhance medication compliance.
